Intractable central post-stroke pain (CPSP) is one of the most common sequelae of stroke, but has been inadequately studied to date. In this study, we first determined the relationship between the lesion site and changes in mechanical or thermal pain sensitivity in a rat CPSP model with experimental thalamic hemorrhage produced by unilateral intra-thalamic collagenase IV (ITC) injection. Then, we evaluated the effi cacy of gabapentin (GBP), an anticonvulsant that binds the voltage-gated Ca 2+ channel α2δ and a commonly used anti-neuropathic pain medication. Histological case-by-case analysis showed that only lesions confined to the medial lemniscus and the ventroposterior lateral/medial nuclei of the thalamus and/or the posterior thalamic nucleus resulted in bilateral mechanical pain hypersensitivity. All of the animals displaying CPSP also had impaired motor coordination, while control rats with intra-thalamic saline developed no central pain or motor deficits. GBP had a dose-related anti-allodynic effect after a single administration (1, 10, or 100 mg/kg) on day 7 post-ITC, with significant effects lasting at least 5 h for the higher doses. However, repeated treatment, once a day for two weeks, resulted in complete loss of effectiveness (drug tolerance) at 10 mg/kg, while effectiveness remained at 100 mg/kg, although the time period of efficacious analgesia was reduced. In addition, GBP did not change the basal pain sensitivity and the motor impairment caused by the ITC lesion, suggesting selective action of GBP on the somatosensory system.
INTRODUCTION
Stroke is the second most common cause of death and is the leading cause of adult disability worldwide [1] . In China, stroke is also the leading cause of death and longterm adult disability, and has an age-adjusted prevalence of 260 to 719 per 100 000 for all ages [2, 3] . Clinically, stroke is classified into two major subtypes, ischemic and hemorrhagic. In a recent INTERSTROKE study, [1] . However, the proportion of ICH is signifi cantly higher in China than in western countries, accounting for 44%-51% of all stroke patients [3, 4] .
Central post-stroke pain (CPSP) is one of the most troublesome sequelae of stroke and can be caused by a primary lesion affecting the central somatosensory system
(at any level of the ascending pathways from the medulla to the cortex) following both IS and ICH [5] [6] [7] [8] [9] [10] [11] [12] . CPSP has been identified in 1%-50% of total patients after stroke of both IS and ICH origins [7, [13] [14] [15] [16] [17] ; however, CPSP is more common in patients with a thalamic stroke, and varies from 11% to 32% [18] [19] [20] [21] [22] [23] . CPSP patients most often present with spontaneous and/or evoked pain (hyperalgesia and allodynia) or paresthesia/dysesthesia in a persistent and/ or paroxysmal form [5] [6] [7] 24] . The distribution, onset time, and clinical characteristics of CPSP vary substantially among patients [7] [8] [9] [10] [11] [12] .
The treatment of CPSP remains an unmet clinical challenge due to its resistance to both pharmacological and non-pharmacological therapies in about half of CPSP patients [9] [10] [11] [12] . The situation has not changed even for patients with peripheral neuropathic pain. For instance, although antidepressants and anticonvulsants are frequently recommended as the first-line drugs for neuropathic pain in general [25] [26] [27] [28] , a large proportion of patients are left with insufficient pain relief due to a limited improvement, according to a review of 174 randomized placebo-controlled trials [29] . To the best of our knowledge, well-designed clinical trials for evaluation of the pharmacological effi cacy of antidepressants and anticonvulsants in patients with CPSP are scarce [30, 31] , leading to a shortage of knowledge on the clinical use of pharmacological therapy. Moreover, the underlying mechanisms of CPSP remain largely unknown due to the lack of experimental studies in animal models [5, [32] [33] [34] [35] .
The analgesic efficacy of gabapentin (GBP), an α2δ-binding anticonvulsant, has been extensively evaluated, and it has been approved in both preclinical and clinical studies for the treatment of various forms of peripheral neuropathic pain (for reviews see refs [25] [26] [27] [28] .
Anticonvulsants (or antiepileptic drugs) have also been recommended for the treatment of central neuropathic pain, especially that associated with spinal cord injury [36] [37] [38] (for reviews see refs 30, 39, 40) . However, the effectiveness of α2δ-binding anticonvulsants (GBP and pregabalin) for the treatment of CPSP has been less studied in either preclinical or clinical research, despite the documentation of other antiepileptic drugs such as carbamazepine, lamotrigine, and phenytoin [30, 40] .
The aims of the present study were: (1) to determine the relationship between lesion site and changes in pain sensitivity of each individual animal following experimental ICH; and (2) to evaluate the pharmacological efficacy of GBP in animals with CPSP hypersensitivity. To determine whether GBP induces tolerance, the dose-effect of repeated GBP injection (once a day for 14 days) was also evaluated.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats weighing 280-320 g were Animals were randomly divided into three groups for establishment of the CPSP model with thalamic hemorrhage: (1) naïve rats without any treatment (n = 6);
(2) rats receiving intra-thalamic microinjection of saline (ITS) (n = 8); and (3) rats receiving intra-thalamic microinjection of collagenase (ITC) (n = 90, 16 for histological analysis, 27 for single GBP administration, 28 for repeated GBP administration and 19 for Rota-rod test).
Surgery
Surgery was performed according to the methods described [34, 41] . Rats were anesthetized with so dium pentobarbital (50 mg/kg, i.p.), and then securely fixed in a stereotaxic instrument (Narishige Scientific Instrument Lab, Japan). After a midline incision, an opening was made in the right skull with a dental drill. An intra-thalamic microinjection of collagenase type IV (Sigma-Aldrich China, Shanghai) or saline was made into the ventral basal complex (VBC) and posterior thalamic nucleus (bregma were allowed to recover in individual cages for at least 7 days. Naïve rats were fed under the same conditions in a parallel manner.
Experimental Design
The experimental procedure is shown in Fig. 1 route of administration of GBP were based on previous reports of its effects on other neuropathic pain models [42] [43] [44] [45] . 
890
To test whether GBP has any effect on baseline pain sensitivity, the highest dose (100 mg/kg, i.p.) was administered to naïve rats. Meanwhile, the effects of intrathalamic injection on motor coordination were also evaluated in both naïve rats and those receiving ITS and ITC (Rotarod test 1 in Fig. 1 ). The pharmacological effects of GBP on motor coordination were also evaluated in rats with CPSP hypersensitivity induced by ITC (Rota-rod test 2 in Fig. 1 ).
Behavioral Tests
All the behavioral tests were performed by experimenters blinded to the treatment. The rats were acclimated to test boxes for >30 min on each of the 5 pre-test days.
Mechanical Sensitivity
Mechanical sensitivity was evaluated with von Frey monofi laments as described previously [46] . Rats were placed on a metal mesh fl oor in a plastic chamber and mechanical stimuli were applied using monofilaments with ascending bending forces of 0.8 g, 2-20 g at 2-g increments, 25, 30, 45 and 60 g.
Each monofilament was applied 10 times (once every several seconds) to t he plantar area of each hind-paw to induce a withdrawal reflex. The bending force of the monofilament able to elicit a 50% withdrawal response was expressed as the paw withdrawal mechanical threshold (PWMT, g).
Thermal Sen sitivity
The thermal sensitivity was determined by measuring the withdrawal latency of the hind-paws in response to radiant heat [46] . The rat was placed on the surface of a 2-mm-thick glass plate in the same plastic chamber. Five heat stimuli repeated at inter-stimulus intervals of 10 min generated by a TC-1 radiant heat stimulator (RTY-3; Xi'an Bobang
Technologies of Chemical Industry Co. Ltd., China) were applied to the plantar area of each hind-paw. The latency was determined as the time from the beginning of the heat stimulus to the appearance of a hind-paw withdrawal reflex.
The last three values were averaged as the mean pawwithdrawal thermal latency (PWTL, s). Baseline latencies were established at 14-20 s to allow a sufficient window for the detection of possible hypersensitivity. A maximal cutoff was set at 30 s to avoid tissue injury.
Rota-rod Test
Motor coordination was tested on a Rota-rod treadmill (Ugo Basile, Italy) [47, 48] . The speed of the Rota-rod was set to increase from 6 to 30 r/min within 2 min. The animals were placed on the treadm ill and the timers started with the onset of acceleration and automatically stopped when the animal fell off, with a cutoff time of 300 s. The test was repeated six times at inter-test intervals of 30 min. The fi rst three times were used for accommodation to the apparatus, and the last three values were recorded for further analysis.
Histological Localization of Injection Sites
After completion of the study, all the animals were sacrificed with an overdose of sodium pentobarbital and perfused transcardially with sterile saline followed by 4%
paraformaldehyde. The brains were removed and stored in 30% sucrose for two days. Frozen sections (25 μm) were cut in the coronal plane and subjected to Nissl staining.
The localization and extent of the lesions were observed under a light microscope (BX51 TR, Olympus, Japan).
Photomicrographs were captured by a computer-based microscope CCD camera (DP-70, Olympus) and processed by Image-Pro-Plus 5.1 (Olympus). A typical example is shown in Fig. 2A .
Statistical Analysis
Data were analyzed using GraphPad Prism version 5
(GraphPad, San Diego, CA) and all data are expressed as mean ± SEM. To check the drug tolerance, percent maximum possible effect (% MPE) was calculated: % MPE = (PWMT h post-GBP -PWMT pre-GBP ) / (PWMT baseline -PWMT pre-GBP ) × 100%, in which h means hours after GBP administration.
Differences in values over time for each group were tested using t-tests and one-way or two-way repeated ANOVA, followed by individual post-hoc comparisons (Tukey or Bonferroni test). P <0.05 was considered as statistically signifi cant.
RESULTS
Central Post-stroke Pain Hypersensitivity in Rats Induced by Experimental Thalamic Hemorrhage
Of 16 rats that received unilateral ITC injection and were histologically examined, 44% (7/16) had no changes in either mechanical or thermal pain sensitivity (#10-16 in Fig. 3 ), while 56% (9/16) developed bilateral mechanical pain hypersensitivity (#1-9 in Fig. 4 ). Among the nine rats with CPSP, two showed accompanying contralateral thermal pain hypersensitivity lasting for 14 days (#1) and 28 days (Fig. 4) . In the remaining six rats (#2-4, #7-9), there was less change in thermal pain sensitivity of the hind-paws from 7-28 days post-ITC (Fig. 4) . None of the naïve rats (n = 6) and rats that received unilateral ITS injection (n = 8) developed pain hypersensitivity to mechanical or heat stimuli (Fig. 5 ). In addition, the ITCinduced bilateral mechanical pain hypersensitivity was identified on day 7 post-operation and the reduced PWMT remained unrelieved until 28 days of observation, suggesting a chronic, persistent bilateral mechanical allodynia in this model (Fig. 5 ).
In each animal that had developed bilateral mechanical pain hypersensitivity, the region of the VBC, equivalent to the ventroposterior lateral nucleus of the thalamus (VPL)/ ventroposterior medial nucleus of the thalamus (VPM), the medial lemniscus and/or the posterior thalamic nucleus (Po) were all or partially involved in the ITC injection sites and area of the lesion (Fig. 4 and Table 1 ). However, in the remaining 7 rats that failed to develop pain hypersensitivity, the ITC injection sites and the lesions were mostly confi ned to the following regions: the internal capsule (#10-12), the middle third of the thalamus (#13), and the lateral and medial geniculate bodies (#14-16) (F ig. 3 and Table 1 ).
Among the nine animals that developed bilateral mechanical pain hypersensitivity after ITC injection, seven showed significant deficits in motor coordination in the Rota-rod test compared with with the naïve rats (n = 6) and rats receiving ITS injection (n = 7) ( Table 2) .
Effects of Gabapentin on Central Post-stroke Mechanical Pain Hypersensitivity Induced by Thalamic Hemorrhage
The time-course of the anti-allodynic effects of GBP was fi rst evaluated in the group of rats that developed bilateral mechanical hypersensitivity on day 7 after ITC injection (see QST 3 in Fig. 1 ). In this experiment, each rat received a single injection of each of the doses of GBP (1, 10, and 100 mg/kg, i.p., 6-8 animals for each dose). Compared with vehicle, single administration of GBP produced a dosedependent anti-allodynic effect in the hypersensitive rats.
The anti-allodynic effect of GBP reached a peak at 1 h after administration and was maintained at a signifi cant level for at least 5 h at higher doses (10 and 100 mg/kg) (Fig. 6A) .
The lowest dose (1 mg/kg) did not have any signifi cant antiallodynic effect throughout the observation period (Fig. 6A ).
The anti-allodynic effect of GBP disappeared completely by 24 h after administration.
The time-course of the long-term anti-allodynic effect of GBP was then evaluated in another group of rats that had developed chronic bilateral mechanical The highest dose of GBP (100 mg/kg) was used (n = 6 for each group).
hypersensitivity. In this chronic setting, each rat received chronic administration of GBP (1, 10, or 100 mg/kg, i.p., 6-8 animals for each dose) once a day for two weeks from day 7 after ITC. QST assessment was performed in each rat with post-stroke pain hypersensitivity on days 7 and 14 after drug administration (14 and 21 days after ITC injection) (Fig. 6B, C, Fig. 7 , also see QST 4 in Fig.   1 ). The dose-dependent pattern of the anti-allodynic effect remained relatively unchanged until 7 days after GBP administration. However, this pattern was disrupted after 14 days, when the anti-allodynic effect disappeared completely at 10 mg/kg although the effect of 100 mg/kg remained relatively unchanged (Fig. 6B, C) . The time-related drug tolerance (% MPE) was clearly seen at 10 mg/kg (Fig.   7A ), while a decreased time-course of drug efficacy also occurred with the highest dose used (100 mg/kg) (Fig. 7B ).
Finally, single or repeated administration of GBP at the highest dose (100 mg/kg) did not produce any changes in baseline pain sensitivity in naïve rats compared with vehicle administration (Fig. S1) . Moreover, single administration of GBP at 100 mg/kg had no significant effect on the motor coordination of naïve rats (Table 3) . No reversal effect was produced by a single administration of GBP at 100 mg/kg on the motor coordination defi cit in rats with CPSP (Table 3) .
DISCUSSION Central Post-stroke Pain Hypersensitivity of Experimental Thalamic Hemorrhage Origin
In the present study, we re-examined the thermal and mechanical pain sensitivity in rats with experimental thalamic hemorrhage induced by local ITC injection according to a previously-reported method [34] . The most prominent characteristic of the model of CPSP in the current study was the development of bilateral mechanical, but not thermal, pain hypersensitivity in both hind-paws. Case-bycase analysis of the relationship between the lesion site and the occurrence of pain hypersensitivity showed that this type of CPSP phenomenon is region-related and caused by unilateral damage of the dorsal column-medial lemniscus-VPL/VPM-Po system, a structural complex that mediates somatosensory functions in both humans and rodents [49] .
Although damage of the internal capsule and the reticular thalamic nucleus was also seen in rats with CPSP, these structures can be excluded because there was less change in either mechanical or thermal pain sensitivity in rats with severe damage mainly confined to these structures (see #10-11 in Fig. 3 and Table 1 ). This result strongly supports the new defi nition of central neuropathic pain: pain caused by a lesion or disease of the central somatosensory nervous system [7, 27, 50, 51] . Our animal data also correlate well with well-designed neuroimaging studies defi ning the lesion site in CPSP patients [52] [53] [54] [55] . In a comparative study of the thalamic lesion sites between patients with and without CPSP [53] , the damage of more posterior, inferior, and lateral parts of the VPL and the anterior pulvinar (equivalent to the Po in rodents) was highly correlated with the occurrence of CPSP. Moreover, the size of the damaged area may also be relevant to the occurrence of CPSP [55] . Although we did not measure the exact volume of the lesions in ITC-induced thalamic damage, the rats with bilateral mechanical pain hypersensitivity had a larger hematoma and secondary surrounding injury than those without CPSP (see Figs. 3 and 4).
So far, CPSP caused by experimental IS or ICH has rarely been studied in animals [56] [57] [58] [59] . The lack of studies on the validity and sensitivity of animal models of CPSP has largely hindered advances in understanding the underlying In the first report, contralateral thermal (hot plate) and mechanical (weight-bearing score and toe-pinch), but not cold (acetone), hypersensitivity were identified during 7-21 days post-ITC [34] , while in the second, bilateral mechanical (von Frey) and cold (acetone), but not thermal (Hargreaves's test with radiant heat), hypersensitivity were identified during 2-32 days post-ITC [32] . In a new mouse model of CPSP caused by ITC and measured using a Dynamic Plantar Anesthesiometer and a Paw Thermal Stimulator [33] , bilateral mechanical and contralateral thermal pain hypersensitivity were found. Taken that the terminations of the dorsal columns are important to the manifestation of tactile allodynia, but not thermal hyperalgesia [60] . Actually, positive or negative thermal pain hypersensitivity is a common phenomenon in patients with CPSP [61] . It has also been proposed that the VMpo is a specific relay for pain and temperature sensation [62, 63] .
In humans, a non-VBC locus lying more posteriorly in the thalamus has been demonstrated to be important for thermo-algesic transmission [54] . Collectively, it is reasonable to expect a lack of thermal hyperalgesia in rats with lesions confined to the medial lemniscus-VPL/VPM/Po, as in our current study.
Furthermore, no limping, foot-dragging, or uneven gait was observed in rats after ITC injection, but the total time on the Rota-rod treadmill was reduced ( Table 2 ). The impairment of motor coordination in rats with thalamic hemorrhage is likely due to proprioceptive dysfunction or motor defi cit rather than mechanical pain hypersensitivity, because the highest dose of GBP (100 mg/kg) had good anti-allodynic efficacy but did not reverse the motor coordination defi cit (Table 3) .
Anti-allodynic Efficacy and Tolerance to Gabapentin in Rats with Central Post-stroke Pain Hypersensitivity
Caused by Thalamic Hemorrhage GBP, a member of a class of anticonvulsants, has a highaffi nity binding site on the α2δ subunit of the voltage-gated Ca 2+ channel (VGCC) in the CNS [64] [65] [66] . GBP modulates neurotransmission presynaptically by inhibiting the release of various neurotransmitters from hyper-excitable or pathophysiological cells via blocking the trafficking of the α2δ1 subunit to the presynaptic membrane [67] [68] [69] [70] . In many models of peripheral neuropathic pain, the α2δ1, but not the α2δ2 (another GBP binding site) subunit of VGCC is significantly up-regulated in both dorsal root ganglia (DRG) and the spinal dorsal horn and contributes to the development of allodynia and hyperalgesia [71] [72] [73] [74] . GBP has therefore been proposed to alleviate neuropathic pain by impairing the traffi cking of α2δ1 to the presynaptic terminals of DRG neurons, leading to a reduction of Ca 2+ infl ux and neurotransmitter release in the dorsal horn, and inhibition of central sensitization [68, 75] .
In the present study, the anti-allodynic effectiveness of GBP was confirmed in rats with central post-stroke mechanical pain hypersensitivity caused by experimental thalamic hemorrhage. The onset and duration of the anti-allodynic effect of GBP following a single intraperitoneal injection were dose-related and in line with its known pharmacokinetic and pharmacodynamic characteristics [44, [76] [77] [78] . The anti-allodynic effect of GBP is not likely to be attributable to the side-effect (sedation) induced by high doses in our study, because no effect on motor coordination was observed after administration of 100 mg/ kg, indicating that GBP is more tolerable than ketamine that has severe motor side-effects [32] . The current results provide evidence for the beneficial use of GBP for the treatment of CPSP in patients after thalamic hemorrhage, in parallel with recent research [35] . However, despite possible side-effects of GBP, such as dizziness and drowsiness, the most intriguing problem we found here was tolerance after repeated administration; this was not reported in the latest research due to the lack of evaluation of dose and timecourse effects [35] . The phenomena of GBP tolerance can be characterized as: (1) loss of anti-allodynic effectiveness after two weeks of administration of a low effective dose (i.e., 10 mg/kg, i.p.), as used in our study; and (2) shortened time-course of anti-allodynic effectiveness after repeated administration of the highest dose (i.e., 100 mg/kg, i.p.).
Actually, these phenomena have frequently been noted in patients with CPSP (personal communications with patients with CPSP), but unfortunately so far this problem has been neglected, even for other patients with neuropathic pain. Experimentally, GBP tolerance has been shown in a rat model of bortezomib-induced painful neuropathy [79] .
In that study, it was reported that administration of GBP (100 mg/kg by gavage every day for 3 weeks) results in a mild anti-allodynic effect on day 4 after treatment, followed by a complete loss of effectiveness afterward, strongly supporting the existence of tolerance to GBP in the treatment of neuropathic pain.
So far, it is not clear where and how GBP acts to produce anti-allodynic effects in this animal model of CPSP, since the systemic route of administration can result in anti-allodynic efficacy at both spinal and supraspinal sites [66, 69] . Moreover, the molecular and cellular mechanisms underlying central post-stroke mechanical pain hypersensitivity remain unclear. Thus, research into the underlying mechanisms of CPSP will be of particular significance for understanding its development and the anti-allodynic effectiveness and tolerance to the drugs [25] [26] [27] [28] . Since it has been proposed that the development of CPSP might be caused by sensitization, disinhibition, and/or neuroplastic changes above the diencephalon [7] , the level of VGCC α2δ subunit expression and the binding sites of GBP is attenuated at a time when α2δ1 subunit protein is abundant [80] . The other possibility is that GBP tolerance might be due to changes in pharmacokinetic and pharmacodynamic characteristics in patients and animals with CPSP. All the above presumptions need further study in this animal model of CPSP.
Using the same CPSP model in mice, a single dose of diclofenac (30 mg/kg, i.p.), morphine (3 mg/kg, i.p.), and pregabalin (10 mg/kg, i.p.) was unable to reverse mechanical and thermal pain hypersensitivity during the period of observation [33] . The lack of therapeutic improvement of pain in patients with CPSP by pregabalin (150 to 600 mg/day) has also been demonstrated in a 13-week, randomized, double-blind, multicenter, placebo-controlled trial [31] . These pre-clinical and clinical results for pregabalin, another α2δ-binding anticonvulsant, are surprising and not conclusive because the authors did not investigate the dose-effect relationship. In contrast, however, in the same report, amitriptyline, lamotrigine, and minocycline (inhibitors of microglial cell activation) were effective in suppressing pain hypersensitivity in mice with CPSP [33] . Moreover, ketamine was able to relieve mechanical and cold pain hypersensitivity only when a high dose (25 mg/kg) was used in the same rat model of CPSP [32] .
In conclusion, our data demonstrate that CPSP produced by ITC injection is a region-specifi c and sensitive model for the evaluation of anti-allodynic drugs, when investigated using case-by-case histological analysis, and provides a useful experimental tool for studying both the mechanisms underlying CPSP and its treatment.
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